As shown in Figure 3, the phosphorylation level of AKT (p-AKT) was reduced in the propranolol treated group compared with the PBS group in MFC tumor (56.82 ± 5.32 vs. 26.16 ± 9.1, P = 0.0196, Figure 3B). Here, AKT1 is linked to neoplasm.